 | • レポートコード：GIR-23F3845 • 出版社/出版日：GlobalInfoResearch / 2023年2月 • レポート形態：英文、PDF、73ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥501,120 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥751,680 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,002,240 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Lanreotide Market」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社（香港）の最新の調査によると、世界のランレオチドの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 ランレオチド市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次を対象にします。 ・60mg、90mg、120mg アプリケーション別セグメントは次のように区分されます。 ・病院、薬局 世界のランレオチド市場の主要なマーケットプレーヤーは以下のとおりです。 ・IPSEN 地域別セグメントは次の地域・国を対象にします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） ***** 目次(一部) ***** ・市場概要 - ランレオチドの概要 - タイプ別分析（2017年vs2021年vs2028年）：60mg、90mg、120mg - アプリケーション別分析（2017年vs2021年vs2028年）：病院、薬局 - 世界のランレオチド市場規模・予測 - 世界のランレオチド生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - IPSEN ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：60mg、90mg、120mg ・アプリケーション別分析2017年-2028年：病院、薬局 ・ランレオチドの北米市場分析 - ランレオチドの北米市場：タイプ別市場規模2017年-2028年 - ランレオチドの北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・ランレオチドのヨーロッパ市場分析 - ：ランレオチドのヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：ランレオチドのヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・ランレオチドのアジア太平洋市場分析 - ランレオチドのアジア太平洋市場：タイプ別市場規模2017年-2028年 - ランレオチドのアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・ランレオチドの南米市場分析 - ランレオチドの南米市場：タイプ別市場規模2017年-2028年 - ランレオチドの南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・ランレオチドの中東・アフリカ市場分析 - ランレオチドの中東・アフリカ市場：タイプ別市場規模2017年-2028年 - ランレオチドの中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Lanreotide market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Lanreotide market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Lanreotide global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 60 mg segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Lanreotide include IPSEN, , , , and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Lanreotide market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
60 mg
90 mg
120 mg
Market segment by Application can be divided into
Hospital
Pharmacy
The key market players for global Lanreotide market are listed below:
IPSEN
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Lanreotide product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Lanreotide, with price, sales, revenue and global market share of Lanreotide from 2019 to 2022.
Chapter 3, the Lanreotide competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Lanreotide breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Lanreotide market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Lanreotide.
Chapter 13, 14, and 15, to describe Lanreotide sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Lanreotide Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Lanreotide Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 60 mg
1.2.3 90 mg
1.2.4 120 mg
1.3 Market Analysis by Application
1.3.1 Overview: Global Lanreotide Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Lanreotide Market Size & Forecast
1.4.1 Global Lanreotide Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Lanreotide Sales in Volume (2017-2028)
1.4.3 Global Lanreotide Price (2017-2028)
1.5 Global Lanreotide Production Capacity Analysis
1.5.1 Global Lanreotide Total Production Capacity (2017-2028)
1.5.2 Global Lanreotide Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Lanreotide Market Drivers
1.6.2 Lanreotide Market Restraints
1.6.3 Lanreotide Trends Analysis
2 Manufacturers Profiles
2.1 IPSEN
2.1.1 IPSEN Details
2.1.2 IPSEN Major Business
2.1.3 IPSEN Lanreotide Product and Services
2.1.4 IPSEN Lanreotide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Lanreotide Breakdown Data by Manufacturer
3.1 Global Lanreotide Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Lanreotide Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Lanreotide
3.4 Market Concentration Rate
3.4.1 Top 3 Lanreotide Manufacturer Market Share in 2021
3.4.2 Top 6 Lanreotide Manufacturer Market Share in 2021
3.5 Global Lanreotide Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Lanreotide Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Lanreotide Market Size by Region
4.1.1 Global Lanreotide Sales in Volume by Region (2017-2028)
4.1.2 Global Lanreotide Revenue by Region (2017-2028)
4.2 North America Lanreotide Revenue (2017-2028)
4.3 Europe Lanreotide Revenue (2017-2028)
4.4 Asia-Pacific Lanreotide Revenue (2017-2028)
4.5 South America Lanreotide Revenue (2017-2028)
4.6 Middle East and Africa Lanreotide Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Lanreotide Sales in Volume by Type (2017-2028)
5.2 Global Lanreotide Revenue by Type (2017-2028)
5.3 Global Lanreotide Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Lanreotide Sales in Volume by Application (2017-2028)
6.2 Global Lanreotide Revenue by Application (2017-2028)
6.3 Global Lanreotide Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Lanreotide Sales by Type (2017-2028)
7.2 North America Lanreotide Sales by Application (2017-2028)
7.3 North America Lanreotide Market Size by Country
7.3.1 North America Lanreotide Sales in Volume by Country (2017-2028)
7.3.2 North America Lanreotide Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Lanreotide Sales by Type (2017-2028)
8.2 Europe Lanreotide Sales by Application (2017-2028)
8.3 Europe Lanreotide Market Size by Country
8.3.1 Europe Lanreotide Sales in Volume by Country (2017-2028)
8.3.2 Europe Lanreotide Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Lanreotide Sales by Type (2017-2028)
9.2 Asia-Pacific Lanreotide Sales by Application (2017-2028)
9.3 Asia-Pacific Lanreotide Market Size by Region
9.3.1 Asia-Pacific Lanreotide Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Lanreotide Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Lanreotide Sales by Type (2017-2028)
10.2 South America Lanreotide Sales by Application (2017-2028)
10.3 South America Lanreotide Market Size by Country
10.3.1 South America Lanreotide Sales in Volume by Country (2017-2028)
10.3.2 South America Lanreotide Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Lanreotide Sales by Type (2017-2028)
11.2 Middle East & Africa Lanreotide Sales by Application (2017-2028)
11.3 Middle East & Africa Lanreotide Market Size by Country
11.3.1 Middle East & Africa Lanreotide Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Lanreotide Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Lanreotide and Key Manufacturers
12.2 Manufacturing Costs Percentage of Lanreotide
12.3 Lanreotide Production Process
12.4 Lanreotide Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Lanreotide Typical Distributors
13.3 Lanreotide Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Table 1. Global Lanreotide Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Lanreotide Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. IPSEN Basic Information, Manufacturing Base and Competitors
Table 4. IPSEN Major Business
Table 5. IPSEN Lanreotide Product and Services
Table 6. IPSEN Lanreotide Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Global Lanreotide Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 8. Global Lanreotide Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 9. Market Position of Manufacturers in Lanreotide, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 10. Global Lanreotide Production Capacity by Company, (K Units): 2020 VS 2021
Table 11. Head Office and Lanreotide Production Site of Key Manufacturer
Table 12. Lanreotide New Entrant and Capacity Expansion Plans
Table 13. Lanreotide Mergers & Acquisitions in the Past Five Years
Table 14. Global Lanreotide Sales by Region (2017-2022) & (K Units)
Table 15. Global Lanreotide Sales by Region (2023-2028) & (K Units)
Table 16. Global Lanreotide Revenue by Region (2017-2022) & (USD Million)
Table 17. Global Lanreotide Revenue by Region (2023-2028) & (USD Million)
Table 18. Global Lanreotide Sales by Type (2017-2022) & (K Units)
Table 19. Global Lanreotide Sales by Type (2023-2028) & (K Units)
Table 20. Global Lanreotide Revenue by Type (2017-2022) & (USD Million)
Table 21. Global Lanreotide Revenue by Type (2023-2028) & (USD Million)
Table 22. Global Lanreotide Price by Type (2017-2022) & (USD/Unit)
Table 23. Global Lanreotide Price by Type (2023-2028) & (USD/Unit)
Table 24. Global Lanreotide Sales by Application (2017-2022) & (K Units)
Table 25. Global Lanreotide Sales by Application (2023-2028) & (K Units)
Table 26. Global Lanreotide Revenue by Application (2017-2022) & (USD Million)
Table 27. Global Lanreotide Revenue by Application (2023-2028) & (USD Million)
Table 28. Global Lanreotide Price by Application (2017-2022) & (USD/Unit)
Table 29. Global Lanreotide Price by Application (2023-2028) & (USD/Unit)
Table 30. North America Lanreotide Sales by Country (2017-2022) & (K Units)
Table 31. North America Lanreotide Sales by Country (2023-2028) & (K Units)
Table 32. North America Lanreotide Revenue by Country (2017-2022) & (USD Million)
Table 33. North America Lanreotide Revenue by Country (2023-2028) & (USD Million)
Table 34. North America Lanreotide Sales by Type (2017-2022) & (K Units)
Table 35. North America Lanreotide Sales by Type (2023-2028) & (K Units)
Table 36. North America Lanreotide Sales by Application (2017-2022) & (K Units)
Table 37. North America Lanreotide Sales by Application (2023-2028) & (K Units)
Table 38. Europe Lanreotide Sales by Country (2017-2022) & (K Units)
Table 39. Europe Lanreotide Sales by Country (2023-2028) & (K Units)
Table 40. Europe Lanreotide Revenue by Country (2017-2022) & (USD Million)
Table 41. Europe Lanreotide Revenue by Country (2023-2028) & (USD Million)
Table 42. Europe Lanreotide Sales by Type (2017-2022) & (K Units)
Table 43. Europe Lanreotide Sales by Type (2023-2028) & (K Units)
Table 44. Europe Lanreotide Sales by Application (2017-2022) & (K Units)
Table 45. Europe Lanreotide Sales by Application (2023-2028) & (K Units)
Table 46. Asia-Pacific Lanreotide Sales by Region (2017-2022) & (K Units)
Table 47. Asia-Pacific Lanreotide Sales by Region (2023-2028) & (K Units)
Table 48. Asia-Pacific Lanreotide Revenue by Region (2017-2022) & (USD Million)
Table 49. Asia-Pacific Lanreotide Revenue by Region (2023-2028) & (USD Million)
Table 50. Asia-Pacific Lanreotide Sales by Type (2017-2022) & (K Units)
Table 51. Asia-Pacific Lanreotide Sales by Type (2023-2028) & (K Units)
Table 52. Asia-Pacific Lanreotide Sales by Application (2017-2022) & (K Units)
Table 53. Asia-Pacific Lanreotide Sales by Application (2023-2028) & (K Units)
Table 54. South America Lanreotide Sales by Country (2017-2022) & (K Units)
Table 55. South America Lanreotide Sales by Country (2023-2028) & (K Units)
Table 56. South America Lanreotide Revenue by Country (2017-2022) & (USD Million)
Table 57. South America Lanreotide Revenue by Country (2023-2028) & (USD Million)
Table 58. South America Lanreotide Sales by Type (2017-2022) & (K Units)
Table 59. South America Lanreotide Sales by Type (2023-2028) & (K Units)
Table 60. South America Lanreotide Sales by Application (2017-2022) & (K Units)
Table 61. South America Lanreotide Sales by Application (2023-2028) & (K Units)
Table 62. Middle East & Africa Lanreotide Sales by Region (2017-2022) & (K Units)
Table 63. Middle East & Africa Lanreotide Sales by Region (2023-2028) & (K Units)
Table 64. Middle East & Africa Lanreotide Revenue by Region (2017-2022) & (USD Million)
Table 65. Middle East & Africa Lanreotide Revenue by Region (2023-2028) & (USD Million)
Table 66. Middle East & Africa Lanreotide Sales by Type (2017-2022) & (K Units)
Table 67. Middle East & Africa Lanreotide Sales by Type (2023-2028) & (K Units)
Table 68. Middle East & Africa Lanreotide Sales by Application (2017-2022) & (K Units)
Table 69. Middle East & Africa Lanreotide Sales by Application (2023-2028) & (K Units)
Table 70. Lanreotide Raw Material
Table 71. Key Manufacturers of Lanreotide Raw Materials
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Lanreotide Typical Distributors
Table 75. Lanreotide Typical Customers
List of Figures
Figure 1. Lanreotide Picture
Figure 2. Global Lanreotide Revenue Market Share by Type in 2021
Figure 3. 60 mg
Figure 4. 90 mg
Figure 5. 120 mg
Figure 6. Global Lanreotide Revenue Market Share by Application in 2021
Figure 7. Hospital
Figure 8. Pharmacy
Figure 9. Global Lanreotide Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Lanreotide Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Lanreotide Sales (2017-2028) & (K Units)
Figure 12. Global Lanreotide Price (2017-2028) & (USD/Unit)
Figure 13. Global Lanreotide Production Capacity (2017-2028) & (K Units)
Figure 14. Global Lanreotide Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Lanreotide Market Drivers
Figure 16. Lanreotide Market Restraints
Figure 17. Lanreotide Market Trends
Figure 18. Global Lanreotide Sales Market Share by Manufacturer in 2021
Figure 19. Global Lanreotide Revenue Market Share by Manufacturer in 2021
Figure 20. Lanreotide Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Lanreotide Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Lanreotide Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Lanreotide Sales Market Share by Region (2017-2028)
Figure 24. Global Lanreotide Revenue Market Share by Region (2017-2028)
Figure 25. North America Lanreotide Revenue (2017-2028) & (USD Million)
Figure 26. Europe Lanreotide Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Lanreotide Revenue (2017-2028) & (USD Million)
Figure 28. South America Lanreotide Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Lanreotide Revenue (2017-2028) & (USD Million)
Figure 30. Global Lanreotide Sales Market Share by Type (2017-2028)
Figure 31. Global Lanreotide Revenue Market Share by Type (2017-2028)
Figure 32. Global Lanreotide Price by Type (2017-2028) & (USD/Unit)
Figure 33. Global Lanreotide Sales Market Share by Application (2017-2028)
Figure 34. Global Lanreotide Revenue Market Share by Application (2017-2028)
Figure 35. Global Lanreotide Price by Application (2017-2028) & (USD/Unit)
Figure 36. North America Lanreotide Sales Market Share by Type (2017-2028)
Figure 37. North America Lanreotide Sales Market Share by Application (2017-2028)
Figure 38. North America Lanreotide Sales Market Share by Country (2017-2028)
Figure 39. North America Lanreotide Revenue Market Share by Country (2017-2028)
Figure 40. United States Lanreotide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Lanreotide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Lanreotide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Lanreotide Sales Market Share by Type (2017-2028)
Figure 44. Europe Lanreotide Sales Market Share by Application (2017-2028)
Figure 45. Europe Lanreotide Sales Market Share by Country (2017-2028)
Figure 46. Europe Lanreotide Revenue Market Share by Country (2017-2028)
Figure 47. Germany Lanreotide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Lanreotide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Lanreotide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Lanreotide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Lanreotide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Lanreotide Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Lanreotide Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Lanreotide Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Lanreotide Revenue Market Share by Region (2017-2028)
Figure 56. China Lanreotide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Lanreotide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Lanreotide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Lanreotide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Lanreotide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Lanreotide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Lanreotide Sales Market Share by Type (2017-2028)
Figure 63. South America Lanreotide Sales Market Share by Application (2017-2028)
Figure 64. South America Lanreotide Sales Market Share by Country (2017-2028)
Figure 65. South America Lanreotide Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Lanreotide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Lanreotide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Lanreotide Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Lanreotide Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Lanreotide Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Lanreotide Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Lanreotide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Lanreotide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Lanreotide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Lanreotide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Lanreotide in 2021
Figure 77. Manufacturing Process Analysis of Lanreotide
Figure 78. Lanreotide Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
• 日本語訳：ランレオチドのグローバル市場2022年
• レポートコード：GIR-23F3845 ▷ お問い合わせ（見積依頼・ご注文・質問）